Thuy Tran

9PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Tumour immunologyMolecular targetsNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 01, 2026
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study.

|Sep 11, 2025
Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes.

Lilach Aizenbud, Noam Savion Gaiger, Ana Luisa Perdigoto

|Mar 25, 2025
MIF as an oncogenic driver of low-heterogeneity melanomas.

Thuy T Tran, Gabriela Athziri Sánchez-Zuno, Rajan P Kulkarni

|May 11, 2024
Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities.

Caroline Naomi Valdez, Gabriela Athziri Sánchez-Zuno, Richard Bucala

|May 11, 2024
MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy.

Rosalyn M Fey, Rebecca A Nichols, Thuy T Tran

|Apr 18, 2024
Vascular mimicry as a facilitator of melanoma brain metastasis.

Olivia K Provance, Victor O Oria, Thuy T Tran

Pageof 2

Frequent Collaborators

2 joint publications

Victor O Oria

2 joint publications

Harriet M Kluger

2 joint publications

Ryan J Sullivan

2 joint publications

Noam Savion Gaiger